Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 192

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia

Open access
Esser, Nathalie, Utzschneider, Kristina M., Kahn, Steven E. · 2020 · Diabetologia

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-020-05245-x

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 75

  1. Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46(1):3–19. https://doi.org/10.1007/s00125-002-1009-0 · DOI · Paper page
  2. Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37(12):1595–1607. https://doi.org/10.2337/diab.37.12.1595 · DOI · Paper page
  3. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14(3):173–194. https://doi.org/10.2337/diacare.14.3.173 · DOI · Paper page
  4. Kruszynska YT, Olefsky JM (1996) Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. J Investig Med 44(8):413–428
  5. Porte D Jr (1991) Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 40(2):166–180. https://doi.org/10.2337/diab.40.2.166 · DOI · Paper page
  6. Fernandez-Castaner M, Biarnes J, Camps I, Ripolles J, Gomez N, Soler J (1996) Beta-cell dysfunction in first-degree relatives of patients with non-insulin-dependent diabetes mellitus. Diabet Med 13(11):953–959. https://doi.org/10.1002/(sici)1096-9136(199611)13:11<953::Aid-dia257>3.0.Co;2-v · doi:10.1002/(sici)1096-9136(199611)13:11<953::aid-dia257>3.0.co;2-v
  7. Pories WJ, Dohm GL (2012) Diabetes: have we got it all wrong? Hyperinsulinism as the culprit: surgery provides the evidence. Diabetes Care 35(12):2438–2442. https://doi.org/10.2337/dc12-0684 · DOI
  8. Corkey BE (2012) Banting lecture 2011. Hyperinsulinemia: cause or consequence? Diabetes 61(1):4–13. https://doi.org/10.2337/db11-1483 · DOI · Paper page
  9. Erion K, Corkey BE (2018) Beta-cell failure or beta-cell abuse? Front Endocrinol 9:532. https://doi.org/10.3389/fendo.2018.00532 · DOI
  10. Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE (2002) Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 51(7):2170–2178. https://doi.org/10.2337/diabetes.51.7.2170 · DOI · Paper page
  11. Festa A, Williams K, D'Agostino R Jr, Wagenknecht LE, Haffner SM (2006) The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 55(4):1114–1120. https://doi.org/10.2337/diabetes.55.04.06.db05-1100 · DOI · Paper page
  12. Stancakova A, Javorsky M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M (2009) Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 58(5):1212–1221. https://doi.org/10.2337/db08-1607 · DOI · Paper page
  13. Staimez LR, Weber MB, Ranjani H et al (2013) Evidence of reduced beta-cell function in Asian Indians with mild dysglycemia. Diabetes Care 36(9):2772–2778. https://doi.org/10.2337/dc12-2290 · DOI
  14. van Haeften TW, Dubbeldam S, Zonderland ML, Erkelens DW (1998) Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests. Diabetes Care 21(2):278–282. https://doi.org/10.2337/diacare.21.2.278 · DOI
  15. Dunaif A, Finegood DT (1996) Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 81(3):942–947. https://doi.org/10.1210/jcem.81.3.8772555 · DOI · Paper page
  16. Xiang AH, Takayanagi M, Black MH et al (2013) Longitudinal changes in insulin sensitivity and beta cell function between women with and without a history of gestational diabetes mellitus. Diabetologia 56(12):2753–2760. https://doi.org/10.1007/s00125-013-3048-0 · DOI
  17. Fujimoto WY, Leonetti DL, Kinyoun JL et al (1987) Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes 36(6):721–729. https://doi.org/10.2337/diab.36.6.721 · DOI · Paper page
  18. Sherry NA, Tsai EB, Herold KC (2005) Natural history of beta-cell function in type 1 diabetes. Diabetes 54(Suppl 2):S32–S39. https://doi.org/10.2337/diabetes.54.suppl_2.s32 · DOI · Paper page
  19. Raffel LJ, Robbins DC, Norris JM et al (1996) The GENNID study. A resource for mapping the genes that cause NIDDM. Diabetes Care 19(8):864–872. https://doi.org/10.2337/diacare.19.8.864 · DOI
  20. Mengozzi A, Tricò D, Nesti L et al (2020) Disruption of fasting and post-load glucose homeostasis are largely independent and sustained by distinct and early major beta-cell function defects: a cross-sectional and longitudinal analysis of the Relationship between Insulin Sensitivity and Cardiovascular risk (RISC) study cohort. Metabolism 105:154185. https://doi.org/10.1016/j.metabol.2020.154185 · DOI
  21. den Biggelaar LJ, Sep SJ, Eussen SJ et al (2017) Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study. Diabetologia 60(3):432–441. https://doi.org/10.1007/s00125-016-4165-3 · DOI
  22. Defronzo RA, Tripathy D, Schwenke DC et al (2013) Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk. Diabetes Care 36(11):3607–3612. https://doi.org/10.2337/dc13-0520 · DOI
  23. Pontiroli AE, Alberetto M, Capra F, Pozza G (1990) The glucose clamp technique for the study of patients with hypoglycemia: insulin resistance as a feature of insulinoma. J Endocrinol Investig 13(3):241–245. https://doi.org/10.1007/bf03349549 · DOI
  24. Del Prato S, Riccio A, Vigili de Kreutzenberg S et al (1993) Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients. Metabolism 42(1):24–29. https://doi.org/10.1016/0026-0495(93)90167-m · DOI
  25. Battezzati A, Terruzzi I, Perseghin G et al (1995) Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma. Diabetes 44(7):837–844. https://doi.org/10.2337/diab.44.7.837 · DOI
  26. Dankner R, Chetrit A, Shanik MH, Raz I, Roth J (2009) Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report. Diabetes Care 32(8):1464–1466. https://doi.org/10.2337/dc09-0153 · DOI
  27. Hulman A, Simmons RK, Brunner EJ et al (2017) Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study. Diabetologia 60(7):1252–1260. https://doi.org/10.1007/s00125-017-4275-6 · DOI
  28. Weyer C, Hanson RL, Tataranni PA, Bogardus C, Pratley RE (2000) A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 49(12):2094–2101. https://doi.org/10.2337/diabetes.49.12.2094 · DOI · Paper page
  29. Trico D, Natali A, Arslanian S, Mari A, Ferrannini E (2018) Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents. JCI Insight 3(24):e124912. https://doi.org/10.1172/jci.insight.124912 · DOI
  30. Andrikopoulos S, Massa CM, Aston-Mourney K et al (2005) Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet. J Endocrinol 187(1):45–53. https://doi.org/10.1677/joe.1.06333 · DOI
  31. Fontaine DA, Davis DB (2016) Attention to background strain is essential for metabolic research: C57BL/6 and the International Knockout Mouse Consortium. Diabetes 65(1):25–33. https://doi.org/10.2337/db15-0982 · DOI · Paper page
  32. Hull RL, Willard JR, Struck MD et al (2017) High fat feeding unmasks variable insulin responses in male C57BL/6 mouse substrains. J Endocrinol 233(1):53–64. https://doi.org/10.1530/JOE-16-0377 · DOI
  33. Hull RL, Kodama K, Utzschneider KM, Carr DB, Prigeon RL, Kahn SE (2005) Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation. Diabetologia 48(7):1350–1358. https://doi.org/10.1007/s00125-005-1772-9 · DOI
  34. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN (1988) Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37(9):1163–1167. https://doi.org/10.2337/diab.37.9.1163 · DOI · Paper page
  35. Parilla JH, Willard JR, Barrow BM, Zraika S (2018) A mouse model of beta-cell dysfunction as seen in human type 2 diabetes. J Diabetes Res 2018:6106051. https://doi.org/10.1155/2018/6106051 · DOI
  36. Kahn CR, Bruning JC, Michael MD, Kulkarni RN (2000) Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes mellitus. J Pediatr Endocrinol Metab 13(Suppl 6):1377–1384. https://doi.org/10.1515/jpem-2000-s611 · DOI
  37. Rossetti L, Stenbit AE, Chen W et al (1997) Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene. J Clin Invest 100(7):1831–1839. https://doi.org/10.1172/jci119711 · DOI
  38. Bruning JC, Michael MD, Winnay JN et al (1998) A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2(5):559–569. https://doi.org/10.1016/s1097-2765(00)80155-0 · DOI · Paper page
  39. Michael MD, Kulkarni RN, Postic C et al (2000) Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6(1):87–97. https://doi.org/10.1016/S1097-2765(05)00015-8 · DOI · Paper page
  40. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96(3):329–339. https://doi.org/10.1016/s0092-8674(00)80546-2 · DOI · Paper page
  41. Larue-Achagiotis C, Goubern M, Laury MC (1988) Concomitant food intake and adipose tissue responses under chronic insulin infusion in rats. Physiol Behav 44(1):95–100. https://doi.org/10.1016/0031-9384(88)90351-4 · DOI
  42. Destefano MB, Stern JS, Castonguay TW (1991) Effect of chronic insulin administration on food intake and body weight in rats. Physiol Behav 50(4):801–806. https://doi.org/10.1016/0031-9384(91)90021-f · DOI
  43. Juan CC, Fang VS, Kwok CF, Perng JC, Chou YC, Ho LT (1999) Exogenous hyperinsulinemia causes insulin resistance, hyperendothelinemia, and subsequent hypertension in rats. Metabolism 48(4):465–471. https://doi.org/10.1016/s0026-0495(99)90105-1 · DOI
  44. Templeman NM, Clee SM, Johnson JD (2015) Suppression of hyperinsulinaemia in growing female mice provides long-term protection against obesity. Diabetologia 58(10):2392–2402. https://doi.org/10.1007/s00125-015-3676-7 · DOI
  45. Templeman NM, Mehran AE, Johnson JD (2016) Hyper-variability in circulating insulin, high fat feeding outcomes, and effects of reducing Ins2 dosage in male Ins1-null mice in a specific pathogen-free facility. PLoS One 11(4):e0153280. https://doi.org/10.1371/journal.pone.0153280 · DOI
  46. Leroux L, Desbois P, Lamotte L et al (2001) Compensatory responses in mice carrying a null mutation for Ins1 or Ins2. Diabetes 50(Suppl 1):S150–S153. https://doi.org/10.2337/diabetes.50.2007.s150 · DOI
  47. Sonnenberg GE, Kemmer FW, Berger M (1990) Exercise in type 1 (insulin-dependent) diabetic patients treated with continuous subcutaneous insulin infusion. Prevention of exercise induced hypoglycaemia. Diabetologia 33(11):696–703. https://doi.org/10.1007/bf00400572 · DOI
  48. Tsalikian E, Kollman C, Tamborlane WB et al (2006) Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care 29(10):2200–2204. https://doi.org/10.2337/dc06-0495 · DOI · Paper page
  49. Zhong VW, Crandell JL, Shay CM et al (2017) Dietary intake and risk of non-severe hypoglycemia in adolescents with type 1 diabetes. J Diabetes Complicat 31(8):1340–1347. https://doi.org/10.1016/j.jdiacomp.2017.04.017 · DOI
  50. Salti I, Bénard E, Detournay B et al (2004) A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 27(10):2306–2311. https://doi.org/10.2337/diacare.27.10.2306 · DOI · Paper page
  51. Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20(4):537–544. https://doi.org/10.2337/diacare.20.4.537 · DOI · Paper page
  52. Alemzadeh R, Langley G, Upchurch L, Smith P, Slonim AE (1998) Beneficial effect of diazoxide in obese hyperinsulinemic adults. J Clin Endocrinol Metab 83(6):1911–1915. https://doi.org/10.1210/jcem.83.6.4852 · DOI
  53. Due A, Flint A, Eriksen G et al (2007) No effect of inhibition of insulin secretion by diazoxide on weight loss in hyperinsulinaemic obese subjects during an 8-week weight-loss diet. Diabetes Obes Metab 9(4):566–574. https://doi.org/10.1111/j.1463-1326.2006.00645.x · DOI
  54. Loves S, van Groningen L, Filius M et al (2018) Effects of diazoxide-mediated insulin suppression on glucose and lipid metabolism in nondiabetic obese men. J Clin Endocrinol Metab 103(6):2346–2353. https://doi.org/10.1210/jc.2018-00161 · DOI
  55. Velasquez-Mieyer PA, Cowan PA, Arheart KL et al (2003) Suppression of insulin secretion is associated with weight loss and altered macronutrient intake and preference in a subset of obese adults. Int J Obes Relat Metab Disord 27(2):219–226. https://doi.org/10.1038/sj.ijo.802227 · DOI
  56. Kahn SE, Klaff LJ, Schwartz MW et al (1990) Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. J Clin Endocrinol Metab 71(4):994–1002. https://doi.org/10.1210/jcem-71-4-994 · DOI
  57. Rosenstock J, Kahn SE, Johansen OE et al (2019) Effect of linagliptin vs glimepiride on major adverse cardiovascular outcomes in patients with type 2 diabetes: the CAROLINA randomized clinical trial. JAMA 322(12):1155–1166. https://doi.org/10.1001/jama.2019.13772 · DOI · Paper page
  58. Reed MA, Pories WJ, Chapman W et al (2011) Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes. J Clin Endocrinol Metab 96(8):2525–2531. https://doi.org/10.1210/jc.2011-0165 · DOI
  59. Corkey BE (2012) Diabetes: have we got it all wrong? Insulin hypersecretion and food additives: cause of obesity and diabetes? Diabetes Care 35(12):2432–2437. https://doi.org/10.2337/dc12-0825 · DOI
  60. Camastra S, Gastaldelli A, Mari A et al (2011) Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia 54(8):2093–2102. https://doi.org/10.1007/s00125-011-2193-6 · DOI · Paper page
  61. Jackness C, Karmally W, Febres G et al (2013) Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and beta-cell function in type 2 diabetic patients. Diabetes 62(9):3027–3032. https://doi.org/10.2337/db12-1762 · DOI · Paper page
  62. Michaliszyn SF, Mari A, Lee S et al (2014) Beta-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes 63(11):3846–3855. https://doi.org/10.2337/db13-1951 · DOI
  63. Zeitler P, Hirst K, Pyle L et al (2012) A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 366(24):2247–2256. https://doi.org/10.1056/NEJMoa1109333 · DOI · Paper page
  64. Giannini C, Weiss R, Cali A et al (2012) Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. Diabetes 61(3):606–614. https://doi.org/10.2337/db11-1111 · DOI
  65. Hosking J, Metcalf BS, Jeffery AN, Streeter AJ, Voss LD, Wilkin TJ (2013) Evidence of early beta-cell deficiency among children who show impaired fasting glucose: 10-yr cohort study (EarlyBird 56). Pediatr Diabetes 14(7):481–489. https://doi.org/10.1111/pedi.12049 · DOI
  66. The RISE Consortium (2018) Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: I. Observations using the hyperglycemic clamp. Diabetes Care 41(8):1696–1706. https://doi.org/10.2337/dc18-0244 · DOI · Paper page
  67. The RISE Consortium (2018) Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: II. Observations using the oral glucose tolerance test. Diabetes Care 41(8):1707–1716. https://doi.org/10.2337/dc18-0243 · DOI
  68. The RISE Consortium (2019) Effects of treatment of impaired glucose tolerance or recently diagnosed type 2 diabetes with metformin alone or in combination with insulin glargine on β-cell function: comparison of responses in youth and adults. Diabetes 68(8):1670–1680. https://doi.org/10.2337/db19-0299 · DOI
  69. Mahajan A, Wessel J, Willems SM et al (2018) Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. Nat Genet 50(4):559–571. https://doi.org/10.1038/s41588-018-0084-1 · DOI · Paper page
  70. Carayol J, Hosking J, Pinkney J et al (2020) Genetic susceptibility determines beta-cell function and fasting glycemia trajectories throughout childhood: a 12-year cohort study (EarlyBird 76). Diabetes Care 43(3):653–660. https://doi.org/10.2337/dc19-0806 · DOI
  71. Giannini C, Dalla Man C, Groop L et al (2014) Co-occurrence of risk alleles in or near genes modulating insulin secretion predisposes obese youth to prediabetes. Diabetes Care 37(2):475–482. https://doi.org/10.2337/dc13-1458 · DOI
  72. Ling C, Ronn T (2019) Epigenetics in human obesity and type 2 diabetes. Cell Metab 29(5):1028–1044. https://doi.org/10.1016/j.cmet.2019.03.009 · DOI · Paper page
  73. van Dijk SJ, Tellam RL, Morrison JL, Muhlhausler BS, Molloy PL (2015) Recent developments on the role of epigenetics in obesity and metabolic disease. Clin Epigenetics 7:66. https://doi.org/10.1186/s13148-015-0101-5 · DOI · Paper page
  74. Attané C, Peyot ML, Lussier R et al (2016) A beta cell ATGL-lipolysis/adipose tissue axis controls energy homeostasis and body weight via insulin secretion in mice. Diabetologia 59(12):2654–2663. https://doi.org/10.1007/s00125-016-4105-2 · DOI
  75. Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21(12):2191–2192. https://doi.org/10.2337/diacare.21.12.2191 · DOI · Paper page

Cited by

See all 192

Metadata

Authors
Esser, N., Utzschneider, K. M., & Kahn, S. E.
Venue
Diabetologia
Published
2020-09-07
Volume
63
Issue
10
Pages
2007-2021
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W3083878863
Cited by
192
References
35
FWCI
21.15
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. https://app.cochat.ai/papers/10.1007/s00125-020-05245-x
The paper
Esser, N., Utzschneider, K. M., & Kahn, S. E. (2020). Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. Diabetologia. https://doi.org/10.1007/s00125-020-05245-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.